Medicines and Aquaculture Notices




NEW ZEALAND GAZETTE, No. 128 — 26 NOVEMBER 2015


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Boostrix

Active Ingredients:
Diphtheria toxoid, adsorbed 2IU
Pertactin 2.5mcg
Pertussis filamentous haemagglutinin 8mcg
Pertussis toxoid, adsorbed 8mcg
Tetanus toxoid, adsorbed 20IU

Dosage Form:
Suspension for injection

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturers:
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
GlaxoSmithKline Biologicals (Saint-Amand-Les-Eaux), Saint-Amand-Les-Eaux, France

Product:
DBL™ Mitoxantrone Hydrochloride Injection Concentrate

Active Ingredient:
Mitoxantrone hydrochloride 2.33mg/mL equivalent to Mitoxantrone 2mg/mL

Dosage Form:
Concentrate for infusion

New Zealand Sponsor:
Hospira NZ Limited

Manufacturers:
Hospira Australia Pty Limited, Melbourne, Australia
Zydus Hospira Oncology Limited (ZHOPL), Ahmedabad, India

Product:
Simponi

Active Ingredient:
Golimumab 50mg

Dosage Form:
Solution for injection

New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited

Manufacturer:
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America

Product:
Simponi SmartJect Injector

Active Ingredient:
Golimumab 50mg

Dosage Form:
Solution for injection

New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited

Manufacturer:
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America

Dated this 20th day of November 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).


Maori Commercial Aquaculture Claims Settlement (Extension to Negotiation Periods for Canterbury, Southland and Wellington) Notice 2015 (Notice No. MPI 563)

Pursuant to section 11(3) of the Maori Commercial Aquaculture Claims Settlement Act 2004 ("the Act"), the Minister for Primary Industries, after complying with the requirements in section 11(4) of that Act, gives the following notice.

Notice

  1. Title and commencement—(1) This notice may be cited as the Maori Commercial Aquaculture Claims Settlement (Extension to Negotiation Periods for Canterbury, Southland and Wellington) Notice 2015.

(2) This notice comes into force on 30 November 2015.

  1. Interpretation—In this notice:


Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2015, No 128





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines (continued from previous page)

🏥 Health & Social Welfare
20 November 2015
Medicines, Boostrix, DBL™ Mitoxantrone Hydrochloride Injection Concentrate, Simponi, Medicines Act 1981
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health

🪶 Maori Commercial Aquaculture Claims Settlement (Extension to Negotiation Periods for Canterbury, Southland and Wellington) Notice 2015

🪶 Māori Affairs
Aquaculture, Settlement, Negotiation Periods, Canterbury, Southland, Wellington